Teneligliptin hydrobromide hydrate
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | Teneligliptin hydrobromide hydrate is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM. |
---|
Catalog Num | A21465 |
---|---|
Formula | C44H67Br5N12O3S2 |
Molecular Weight | 1275.7 |
CAS Number | 1572583-29-9 |
SMILES | CC1=NN(C2=CC=CC=C2)C(N3CCN([C@]4([H])CN[C@H](C(N5CSCC5)=O)C4)CC3)=C1.CC6=NN(C7=CC=CC=C7)C(N8CCN([C@]9([H])CN[C@H](C(N%10CSCC%10)=O)C9)CC8)=C6.Br.Br.Br.Br.Br.O |
Synonyms | MP-513 hydrobromide hydrate, MP513, MP 513 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2